Clinical Trial: A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024316) titled 'A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP' on June 03.

Brief Summary: This is a study to investigate the effect of oral ATL-001 (ciclopirox) in CEP (Congenital Erythropoietic Porphyria) patients. During the study, it will be measured the improvement of skin lesions, fatigue and other clinical symptoms as well as blood parameters

Study Start Date: Nov. 01, 2025

Study Type: INTERVENTIONAL

Condition: Congenital Erythropoietic Porphyria (CEP)

Intervention: ...